Western tradition · NAD Precursor

Nicotinamide (Niacinamide / B3)

The simplest and cheapest NAD+ precursor — with extensive human trial data in skin aging and DNA repair.

↑ iHerb link is an affiliate link — we may earn a commission at no cost to you.

Origin & tradition

Not traditional as a longevity supplement: niacinamide is a B3 vitamin known since the 1930s and widely used in dermatology.

Why longevity buyers care

Key active: Nicotinamide — NAD+ precursor via NAMPT salvage pathway.

Nicotinamide is metabolized via NAMPT (rate-limiting salvage enzyme). High doses (>1g) may inhibit SIRT1/PARP activity; lower doses (250–500mg) are preferred for longevity stacks. Strong human evidence for UV-induced DNA damage repair, non-melanoma skin cancer prevention, and skin aging — a unique dermatology profile not shared by NMN or NR.

Effect summary

Studied health outcomes

Editorial summary — This table is curated by hand from published research consensus, not automatically calculated from our trial database. Grades reflect our interpretation of the literature. Treat as a starting point, not a definitive verdict. See the Evidence panel below for the underlying trial and paper counts sourced directly from ClinicalTrials.gov and PubMed.
Health outcomeEffectMagnitudeGrade
NAD+ levels (blood)IncreasesStrongA
Skin cancer (non-melanoma) incidenceDecreasesModerateA
DNA repair markersIncreasesModerateB
Skin health (topical and oral)IncreasesModerateA
Kidney protection (CKD progression)DecreasesMinorC

Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data

Dosage guidance

How Nicotinamide (Niacinamide / B3) is typically used

Typical dose
250–500 mg/day (for NAD+ support); up to 1,500 mg for skin cancer prevention
Form
tablet or capsule (niacinamide / nicotinamide — flush-free, distinct from niacin)
Timing
any time, with or without food

Nicotinamide (niacinamide) is flush-free unlike niacin. Raises NAD+ comparably to NR at a fraction of the cost. At 500mg 3×/day, it reduced skin cancer incidence in a phase 3 RCT. At very high doses (>3g/day), may inhibit sirtuins — keep dose moderate.

Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.

Evidence summary

What the research actually says

76Evidence confidence
Extensive human-trial evidence953 randomized controlled trials · 365 meta-analyses / systematic reviews

Extensive human RCTs (skin cancer prevention, dermatology); NAD/longevity trials ongoing

Nicotinamide is metabolized via NAMPT (rate-limiting salvage enzyme). High doses (>1g) may inhibit SIRT1/PARP activity; lower doses (250–500mg) are preferred for longevity stacks. Strong human evidence for UV-induced DNA damage repair, non-melanoma skin cancer prevention, and skin aging — a unique dermatology profile not shared by NMN or NR.

67registered clinical trials reference this intervention
    3selected from 4+ PubMed papers (longevity / aging angle)
    Key active: Nicotinamide — NAD+ precursor via NAMPT salvage pathway.

    According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-06-12. They include trials across many endpoints, not only longevity.

    Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.

    Compare the evidence

    Related ingredients

    Suppliers

    No Nicotinamide (Niacinamide / B3) suppliers listed yet

    Tell us what you need and we will source suppliers for you.

    Request sourcing help